TAR-0520 gel matching vehicle without active ingredients, TAR-0520 Gel
TARIAN 007
Phase 2 small_molecule active
Quick answer
TAR-0520 gel matching vehicle without active ingredients, TAR-0520 Gel for EGFR inhibitor-induced folliculitis is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- EGFR inhibitor-induced folliculitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active